CMS Updates Prostate Cancer Screening Coverage Policy (NCD 268) for 2026

CMS has issued a modification to National Coverage Determination (NCD) 268, which governs Medicare coverage for prostate cancer screening tests. The update, effective March 12, 2026, reaffirms and clarifies the coverage framework for two core screening procedures: the screening digital rectal examination and the screening prostate specific antigen (PSA) blood test. Billing teams and revenue cycle managers should review their documentation workflows now to ensure claims meet the age, frequency, and ordering provider requirements spelled out in this policy.

Field	Detail
Payer	Centers for Medicare & Medicaid Services (CMS)
Policy	Prostate Cancer Screening Tests
Policy Code	NCD 268
Change Type	Modified
Effective Date	2026-03-12
Impact Level	Medium
Specialties Affected	Urology, Primary Care/Internal Medicine, Family Medicine, Geriatrics, Nurse Practitioners/PAs in Men's Health
Key Action	Verify that all screening claims meet the age-50 threshold, 12-month frequency limit, and ordering/performing provider qualifications before submitting to Medicare.

---

What NCD 268 Covers: CMS Prostate Cancer Screening Tests

NCD 268 traces its statutory authority to Section 4103 of the Balanced Budget Act of 1997, which established Medicare coverage for prostate cancer screening as a defined benefit category. The Centers for Medicare & Medicaid Services covers two screening procedures under this NCD:

• Screening digital rectal examination (DRE): A clinical examination of the prostate for nodules or other abnormalities.
• Screening prostate specific antigen (PSA) test: A blood test detecting the marker for adenocarcinoma of the prostate—a reliable immunocytochemical marker for both primary and metastatic disease.

These are preventive/screening benefits, which means they carry their own set of coverage rules distinct from diagnostic prostate evaluations. The distinction matters at the claim level: screening codes and diagnostic codes are not interchangeable, and miscoding a screening visit as a diagnostic service (or vice versa) is a common source of denials and compliance exposure.

---

Medicare Prostate Screening Eligibility: Age and Frequency Requirements

Both covered services carry identical eligibility thresholds under NCD 268:

Age requirement: The beneficiary must have attained age 50.

Frequency limit: Each service is covered once every 12 months. CMS defines "12 months" with a specific technical rule—at least 11 months must have passed following the month in which the last Medicare-covered screening was performed. This is not a simple calendar-year reset. If a patient received a covered PSA screening in April 2025, the earliest Medicare will cover the next one is April 2026 (with the claim reflecting service on or after the first day of that month).

This frequency calculation is a routine source of claim rejections. Your billing team should be pulling prior claim history—not just relying on the patient's self-reported date of last screening—before submitting.

---

Provider Qualifications: Who Can Order and Perform These Screenings

NCD 268 is explicit about which providers can perform or order these services, and the requirements differ slightly between the two procedures.

Screening Digital Rectal Examination

The DRE must be performed by one of the following:

• A doctor of medicine or osteopathy (as defined in §1861(r)(1) of the Act)
• A physician assistant, nurse practitioner, clinical nurse specialist, or certified nurse midwife—provided they are authorized under state law to perform the examination

In all cases, the performing provider must be fully knowledgeable about the beneficiary's medical condition and responsible for using the results in the overall management of the patient's specific medical problem. Credential and scope-of-practice documentation should be part of your credentialing file for any mid-level provider billing this service under Medicare.

Screening PSA Test

The PSA test must be ordered by:

• The beneficiary's physician (doctor of medicine or osteopathy)
• A physician assistant, nurse practitioner, clinical nurse specialist, or certified nurse midwife

The same knowledge and management-responsibility standard applies. The ordering provider must be fully knowledgeable about the patient's condition and would be responsible for using the test results in managing the patient's specific medical problem.

One practical note: the PSA is a lab test ordered by the provider and performed by the lab—so your billing workflow involves both the ordering provider's documentation and the lab's claim submission. Make sure the ordering provider's NPI is captured correctly on lab claims, and that the lab is referencing the correct benefit category.

---

Affected Codes

This policy does not list specific CPT or HCPCS codes in the current policy document. CMS directs readers to claims processing instructions for applicable code assignments. Billing teams should reference the Medicare Claims Processing Manual and their Medicare Administrative Contractor (MAC) for the current procedure codes associated with screening DRE and screening PSA services under NCD 268.

Common codes historically associated with these services (verify with your MAC):

⚠️ Note: The following are provided for context only. Always confirm current active codes with your MAC, as NCD 268 itself does not enumerate specific codes.

Screening PSA tests and screening DREs are typically billed under the G-code series for preventive services in the Medicare fee schedule. Your MAC's LCD or billing guidance will specify the exact codes applicable to your jurisdiction.

Related ICD-10 Diagnosis Codes

This policy does not enumerate specific ICD-10-CM codes. Diagnosis coding for these services typically supports medical necessity documentation or routes the claim to the correct benefit category. Work with your coding team to confirm appropriate Z-code (screening) versus N-code (symptomatic/diagnostic) assignment based on clinical context.

---

Coverage Limitations and Non-Covered Scenarios

NCD 268 establishes coverage within clear boundaries. Services that fall outside those boundaries are not covered under this NCD:

• Beneficiaries under age 50 — no coverage regardless of clinical indication under this screening benefit (diagnostic workup would be a separate claim pathway)
• Claims submitted before the 12-month frequency window has elapsed — these will deny; prior authorization does not exist for this service, so the only protection is accurate eligibility verification
• Services performed by providers outside the defined qualifying categories — mid-level providers operating outside their state-authorized scope of practice would not satisfy coverage criteria
• Services ordered or performed without the provider meeting the "fully knowledgeable" and management-responsibility standard — while difficult to audit at submission, this is a documentation compliance requirement

There are no prior authorization requirements noted in NCD 268, and no experimental or investigational designations apply to these procedures under this policy.

---

What Your Billing Team Should Do

Copy Action Items

---